PF-Atlas › Clinical Trials › NCT05383131

To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

HEC585 · Phase 1

Registry ID
NCT05383131
Phase
Phase 1
Status
Completed
Drug / intervention
HEC585
Sponsor
Sunshine Lake Pharma Co., Ltd.
Start
2021-06-23
Enrollment
33
Locations
1

About this trial

An open label study to evaluate drug-drug interactions between HEC585 and Pirfenidone or Nintedanib in healthy volunteers

View NCT05383131 on ClinicalTrials.gov →

Explore related

All HEC585 trialsAll IPF trials

Related trials

HEC585 — NCT03092102HEC585 — NCT05060822HEC585 — NCT04512170
Medical disclaimer. This page summarizes public trial data for NCT05383131 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.